DEGS1 inhibition for insulin resistance and hepatic steatosis

DISEASE CATEGORY: Endocrine/metabolic; hepatic

INDICATION: Diabetes; hepatic

A University of Utah team led by Centaurus Therapeutics

Read the full 155 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE